| Dr Cory Lynn Seylar, OD | |
|
494 Gateway Ave, Chambersburg, PA 17201-7351 | |
| (717) 263-6186 | |
| (717) 263-6888 |
| Full Name | Dr Cory Lynn Seylar |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 494 Gateway Ave, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033196472 | NPI | - | NPPES |
| 0015389300008 | Medicaid | PA | |
| 406230200 | Medicaid | MD | |
| 1011733040002 | Medicaid | PA | |
| 402812100 | Medicaid | MD | |
| P00065384 | Other | PA | RAILROAD MEDICARE |
| CG7940 | Other | PA | RAILROAD MEDICARE |
| CG7940 | Other | MD | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG000873 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ludwick Eye Center, Ltd | 4183522972 | 12 |
| Myeyedr Optometry Of Pennsylvania Llc | 3971884883 | 89 |
| Ludwick Eye Center, Ltd | 4183522972 | 12 |
News Archive
In a new study a genetic mutation was found in the most common form of ovarian cancer. This according to the US scientists could pave the way for a more effective treatment of the disease. The detailed genetic map already helped scientists identify existing drugs with the potential for treating the mutations found in ovarian cancer tumors and also identified mutations that could respond to new drugs.
A team of New York-based researchers has compared the effects of two disease-causing mutations, potentially explaining why patients with the rare genetic disorder keratitis-ichthyosis-deafness (KID) syndrome can experience different sets of symptoms.
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.
Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.
› Verified 3 days ago
| Provider Name | Ludwick Eye Center, Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063499531 PECOS PAC ID: 4183522972 Enrollment ID: O20031231000043 |
News Archive
In a new study a genetic mutation was found in the most common form of ovarian cancer. This according to the US scientists could pave the way for a more effective treatment of the disease. The detailed genetic map already helped scientists identify existing drugs with the potential for treating the mutations found in ovarian cancer tumors and also identified mutations that could respond to new drugs.
A team of New York-based researchers has compared the effects of two disease-causing mutations, potentially explaining why patients with the rare genetic disorder keratitis-ichthyosis-deafness (KID) syndrome can experience different sets of symptoms.
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.
Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.
› Verified 3 days ago
| Provider Name | Myeyedr Optometry Of Maryland Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609204437 PECOS PAC ID: 6002037629 Enrollment ID: O20141024000821 |
News Archive
In a new study a genetic mutation was found in the most common form of ovarian cancer. This according to the US scientists could pave the way for a more effective treatment of the disease. The detailed genetic map already helped scientists identify existing drugs with the potential for treating the mutations found in ovarian cancer tumors and also identified mutations that could respond to new drugs.
A team of New York-based researchers has compared the effects of two disease-causing mutations, potentially explaining why patients with the rare genetic disorder keratitis-ichthyosis-deafness (KID) syndrome can experience different sets of symptoms.
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.
Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cory Lynn Seylar, OD 8614 Westwood Center Dr Fl 9, Vienna, VA 22182-2442 Ph: (703) 847-8899 | Dr Cory Lynn Seylar, OD 494 Gateway Ave, Chambersburg, PA 17201-7351 Ph: (717) 263-6186 |
News Archive
In a new study a genetic mutation was found in the most common form of ovarian cancer. This according to the US scientists could pave the way for a more effective treatment of the disease. The detailed genetic map already helped scientists identify existing drugs with the potential for treating the mutations found in ovarian cancer tumors and also identified mutations that could respond to new drugs.
A team of New York-based researchers has compared the effects of two disease-causing mutations, potentially explaining why patients with the rare genetic disorder keratitis-ichthyosis-deafness (KID) syndrome can experience different sets of symptoms.
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.
Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.
› Verified 3 days ago
Joel Howard Mcgahen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 422 Phoenix Dr, Chambersburg, PA 17201 Phone: 717-264-4012 Fax: 717-264-5745 | |
Bryan J. Lohr And Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1730 Lincoln Way E, Chambersburg, PA 17202 Phone: 717-267-3038 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1714 Lincoln Way E Ste 13, Chambersburg, PA 17202 Phone: 717-753-6465 | |
Allegany Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 626 Chambersburg Mall, Chambersburg, PA 17202 Phone: 717-263-7050 Fax: 717-263-3277 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 626 Chambersburg Mall, Chambersburg, PA 17202 Phone: 717-263-7050 | |
Future Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 494 Gateway Ave., Chambersburg, PA 17201 Phone: 717-263-6186 Fax: 717-263-6888 |